(a)A public corporation seeking to propose or to prescribe regulation shall publish to the public, no later than upon its prescription, and if the regulation is a bill laid on the table of the Knesset or regulations brought before a committee of the Knesset committees – at the time of their being brought before the Knesset, a report that shall include, inter alia, all of the following:
(1)the main features of the regulation, its objectives, the reasons for its prescription and the expected benefit from its prescription;
(2)the main alternatives that were examined and the reason for choosing the chosen alternative;
(3)a description of direct and indirect effects expected to result from the regulation on protected interests, in addition to the interest for the realisation of which the regulation was prescribed.
(b)A public corporation shall publish on its website guidelines that it has set with respect to the manner of implementing subsection (a), including guidelines on the following matters:
(1)the manner of conducting a public participation process and details thereof to be included in the report referred to in subsection (a), and the transparency of the process;
(2)the manner of describing the direct effects, including a description of the cost of compliance with the regulation, and the cases in which an assessment of the cost is required and the manner of carrying it out, as well as the manner of describing significant effects on competition, if any;
(3)examination of the existence of parallel or conflicting provisions in existing regulation;
(4)the manner of making the regulation accessible to the public, including by digital means;
(5)the manner and types of cases in which the accepted rules in countries with significant markets shall generally be taken into account in prescribing the regulation;
(6)the level of detail of the report having regard to the scope of the effects referred to in subsection (a)(3) and the scope of the discretion vested in the regulator in prescribing the regulation.
(c)Notwithstanding the provisions of subsection (a), a public corporation may refrain from publishing a report as referred to therein with respect to regulation that it seeks to propose or to prescribe, if it finds that one of the following applies, provided that it has published the reasons therefor on its website:
(1)there is a concern of real harm to a protected interest for the sake of which urgent prescription of the regulation is required;
(2)the direct and indirect effects expected to result from the regulation on the parties to whom it is intended to apply or on other protected interests, including the cost of compliance therewith, are not material;
(3)publication of the report is liable to cause harm to the stability of the financial system and its orderly operation, to the stability or proper management of the bodies belonging to that system, or to cause significant harm to the interests of investors or customers of such bodies;
(4)the regulation is based, with the necessary adaptations, on accepted rules in countries with significant markets, which guide the public corporation in its area of activity;
(5)the regulation extends the period of validity of existing regulation for a period not exceeding one year;
(6)the circumstances referred to in the opening passage of section 27(g) apply to the regulation;
(7)the regulation concerns the prescription of professional ethics rules;
(8)the regulation was prescribed by way of regulatory approval, and the public corporation was of the opinion, having regard to the nature and character of the approval, that publishing a report as referred to in subsection (a) is liable to harm its activities or the activities of the parties to whom the regulation applies;
(9)pursuant to Government decisions, a regulator who sought to propose or to prescribe regulation of a nature or character similar to it would not have been required to carry out a regulation impact assessment process for that purpose;
(10)other circumstances determined by the Prime Minister by Regulations, after consultation with the Minister of Finance and the Minister of Justice, and with the approval of the Finance Committee of the Knesset, by reason of which it is justified not to publish a report as referred to in subsection (a) with respect to the regulation.
(d)The power under subsection (c)(1) shall be vested in a public corporation only with respect to regulation the period of validity of which does not exceed two years; however, if the regulation was proposed or prescribed such that its period of validity exceeds two years, the report shall be published within a reasonable time after its prescription.
(e)A public corporation shall not include in a report that it publishes pursuant to the provisions of subsection (a) information that may not be disclosed pursuant to section 9(a) of the Freedom of Information Law, and it may refrain from including in such report information that there is no obligation to disclose pursuant to section 9(b) of that Law.
(f)A public corporation shall maintain a mechanism for monitoring compliance with the provisions of this Section.